@vitalpointtech1 Profile picture

VitalPointTech

@vitalpointtech1

Tech-enabled Innovative Healthcare platform developing alternatives solutions including CBD, ketamine & psilocybin for PTSD, opioid addiction & mental health

Similar User
jnybgood photo

@jnybgood2000

claude photo

@allezlombcit

DTC photo

@DTCtrades

Big Green Tractor photo

@kp2337

BBstocks photo

@BZstockss

BMF photo

@BMF_MONEY

Ola's Investments 🇺🇲🇨🇦🇮🇱🇬🇧 photo

@Olataytay

@Dr_Brick_Top 🥇 ✈️ 📡 photo

@dr_brick_top

𝖳𝖱𝖠𝖣𝖤𝖱99 photo

@pennytrader99

Rich photo

@RichOTCtrader

STOCK HunTeR photo

@ARNRAY777

drumkid photo

@superlars34

Pablo El'Patron ................Lets do this!!!! photo

@pablostockbar

Pharmagreen Biotech Inc photo

@pharmagreeninc

elks photo

@jimremick

VitalPointTech Reposted

FDA Approves Long-Awaited Clinical Trial Of Smoked Marijuana To Treat PTSD In Veterans: "After 3 years of negotiations with the FDA, this decision opens the door to future research into cannabis...offering hope to millions." marijuanamoment.net/fda-approves-l…


VitalPointTech Reposted

Interest in psychedelic therapy is growing, but most studies focus on synthetic compounds. In fact, of the 198 studies posted on clinicaltrials.gov, of which 49 have been completed with the molecule yet only 1 with psilocybin mushrooms. Insights from our Roots To Thrive…

Tweet Image 1

VitalPointTech Reposted

Psychedelic St Valentine? Planning to take MDMA, a psychedelic drug/attend a psychedelic retreat with your romantic partner and want to help psychedelic research? Imperial College London is now investigating the long-term effects of taking psychedelics, MDMA, ketamine, 2C-B,…


Patients should have the right of choice and not be a stigmatized because of it. we strive to provide quality information and improve the standards of alternative medicine.

Jim Cramer on @elonmusk’s Ketamine use: “Here’s a man who admits he had depression, admits that he’s taking a drug that had helped million of people, and for that he’s pilloried? There are many people who would never be brave enough to admit that they take this drug.”



VitalPointTech Reposted

Nice to see Japan catching up with the psychedelic therapy studies... This new study from Keio University's Neuro-psychiatry Dept. @keionp61 here in Tokyo showing efficacy of IV ketamine against treatment-resistant depression... Psilocybin next... onlinelibrary.wiley.com/doi/10.1111/pc…

Tweet Image 1

VitalPointTech Reposted

Flashback for those worried about a Trump administration and cannabis. @TheDalesReport @V_arrell Note the mention of Safe Banking.

Legalizing marijuana won’t just get people out of jail and back to work — it can actually help solve America’s drug addiction problem. #Kennedy24



VitalPointTech Reposted

What Donald Trump's Presidential Election Means For Marijuana Reform: On the campaign trail, Trump took many by surprise when he endorsed a Florida cannabis legalization ballot initiative, along with federal marijuana rescheduling and banking reform. marijuanamoment.net/what-donald-tr…


Vitalpoint Technologies Appoints Dr. Joseph Rosado, MD, MBA to the role of Chief Medical Officer with a Focus on Ketamine Research and Accessibility vitalpointtech.com/vitalpoint-tec…


VitalPoint Technologies, Inc. Announces Closing of Deal with AppCo to Revolutionize Alternative Health Solutions – VitalPoint Technologies, Inc. vitalpointtech.com/vitalpoint-tec…


VitalPointTech Reposted

DEA Acknowledges New Two-Step Test For Marijuana's Accepted Medical Use Is Legitimate: "It means that they recognize that they're bound by a higher authority." marijuanamoment.net/dea-acknowledg…


"Psilocybin is a hallucinogenic compound that is showing promise in the ability to treat neurological conditions such as depression and post-traumatic stress disorder" pubmed.ncbi.nlm.nih.gov/35882885/


VitalPointTech Reposted

🌿 "Cannabis was rated as the most effective self-management strategy to reduce symptom intensity," researchers determined. norml.org/news/2024/09/0…


Alternative health and therapies are the future of healthcare!

Depression: Five Million Americans May Benefit From Psychedelic Therapy newsweek.com/depression-ame…



VitalPointTech Reposted

Marijuana Use By Older Americans Has Nearly Doubled In The Last Three Years, AARP-Backed Study Shows: 81 percent said they use cannabis to relax, 68 percent said it aids sleep and 64 percent said it was simply to enjoy the drug's effects and feel good. marijuanamoment.net/marijuana-use-…


Loading...

Something went wrong.


Something went wrong.